JAK inhibitors in psoriatic disease
M Megna, L Potestio, A Ruggiero… - Clinical, Cosmetic …, 2023 - Taylor & Francis
Psoriasis is now considered to be the cutaneous phenotype of a systemic inflammatory
condition, recognized under the term Psoriatic Disease (PsD). PsD has several …
condition, recognized under the term Psoriatic Disease (PsD). PsD has several …
Secukinumab in Hidradenitis Suppurativa patients who failed Adalimumab: A 52-week real-life study
F Martora, C Marasca, S Cacciapuoti… - Clinical, Cosmetic …, 2024 - Taylor & Francis
Background The treatment of hidradenitis suppurativa (HS) has always been a real
challenge for dermatologists; to date, adalimumab the only biologic drug approved for HS is …
challenge for dermatologists; to date, adalimumab the only biologic drug approved for HS is …
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
F Martora, T Battista, L Potestio… - Clinical, Cosmetic …, 2024 - Taylor & Francis
Managing HS has long posed a significant challenge for dermatologists. Adalimumab
stands as the sole biologic drug sanctioned for HS, receiving approval in 2015 as an anti …
stands as the sole biologic drug sanctioned for HS, receiving approval in 2015 as an anti …
[PDF][PDF] GUIDANCE IN HIDRADENITIS SUPPURATIVA MANAGEMENT.
R OLTEANU, P MANDISODZA, T ANDRONIC… - Dermatovenerologia …, 2024 - revistasrd.ro
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by
painful nodules, abscesses, and fistulas in intertriginous areas. Immune-mediated …
painful nodules, abscesses, and fistulas in intertriginous areas. Immune-mediated …
[PDF][PDF] OPÞIUNI ÎN MANAGEMENTUL HIDRADENITEI SUPURATIVE GUIDANCE IN HIDRADENITIS SUPPURATIVA MANAGEMENT
R OLTEANU, P MANDISODZA, T ANDRONIC… - revistasrd.ro
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by
painful nodules, abscesses, and fistulas in intertriginous areas. Immunemediated …
painful nodules, abscesses, and fistulas in intertriginous areas. Immunemediated …
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration–A Case Report
F Martora, MC Annunziata, L Potestio… - Clinical, Cosmetic …, 2024 - Taylor & Francis
This case study outlines the management of a 24-year-old male with a history of juvenile
nephronophthisis who underwent renal transplantation at age 12 and later required dialysis …
nephronophthisis who underwent renal transplantation at age 12 and later required dialysis …